A Study of LY3463251 in Healthy Participants

NCT03764774 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

118

Enrollment

INDUSTRY

Sponsor class

Stopped Trial was terminated due to an insufficient benefit/tolerability ratio

Conditions

Healthy

Interventions

DRUG: LY3463251
DRUG: Placebo

Sponsor

Eli Lilly and Company